Analysis of facors associated with successful smoking cessation and continuous abstinence after smoking cessation therapy at our clinic

Bibliographic Information

Other Title
  • 当クリニックにおける禁煙外来の治療成績及びそれに関連する要因の検討

Search this article

Abstract

In Japan, nicotine dependence care service has been started under public health insurance coverage since 2006. Varenicline tartrate (Champix®), an oral agent for smoking cessation therapy, has been prescribed under health insurance coverage since 2008.<br>From October 2009 to March 2013, we collected 130 smokers (male 97, female 33) who received smoking cessation treatment with varenicline at our clinic. We classified these patients into two groups (successful group and failed group), and analyzed the difference of five variables (age, gender, Brinkman index, Tobacco Dependence Screener score and exhaled carbon monoxide level at first visit) between two groups.<br>Of 130 patients who received treatment, 93 patients (71.5%) were classified into successful group. A significant difference was observed only in Brinkman index between two groups (p=0.037). Brinkman index of successful group was higher than failed group (619 vs 491).<br>Of 93 successful patients, 69 patients (74.2%) completed five visits to outpatient clinic during 12 weeks’ therapy program. Of 37 failed patients, only 5 patients (13.5%) completed five visits.<br>Of 93 successful patients, 24 patients (25.8%) did not complete five visits to outpatient clinic. Continuous abstinence rate of 69 full-visit patients after 2 years from therapy program was 51.1%. In contrast, continuous abstinence rate of 24 incomplete-visit patients was only 31.7%.<br>Successful smoking cessation at the end of therapy program was associated with the achievement of full five visits to outpatient clinic. Continuous abstinence after smoking cessation therapy was also associated with the achievement of full visits to clinic during the program.

Journal

Citations (1)*help

See more

References(5)*help

See more

Details 詳細情報について

Report a problem

Back to top